NVS: Novartis AG Stocks News on July 26, 2024

Dren Bio and Novartis link on bispecific antibodies for cancer

NVS

Pharmaceutical Technology

2 days ago

Dren Bio and Novartis link on bispecific antibodies for cancer

Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?

NVS

Zacks

2 days ago

Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?

Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board

NVS

BioPharma Dive

3 days ago

Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board

NVS

MT Newswires

4 days ago

DA Davidson Raises Price Target on Novartis to $120 From $110, Maintains Buy/Add Rating

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

NVS

Zacks

4 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

NVS

Argus Research

7 days ago

Analyst Report: Novartis AG

NVS

Argus Research

7 days ago

Market Update: NVS, AXP, DPZ, EFX, MTB, CRWD

Ionis (IONS) Completes Enrolment for Rare Disease Drug Study

NVS

Zacks

7 days ago

Ionis (IONS) Completes Enrolment for Rare Disease Drug Study

Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data

NVS

Zacks

7 days ago

Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

NVS

BioPharma Dive

8 days ago

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

Novartis Ag (NVS) Q2 2024 Earnings Call Transcript

NVS

Motley Fool

8 days ago

Novartis Ag (NVS) Q2 2024 Earnings Call Transcript

Novartis Dives After Handing Amgen, Bristol — And Their Rivals — A Key Victory

NVS

Investor's Business Daily

8 days ago

Novartis Dives After Handing Amgen, Bristol — And Their Rivals — A Key Victory

Why Novartis Stock Is Down Today Despite Topping Q2 Estimates

NVS

Motley Fool

8 days ago

Why Novartis Stock Is Down Today Despite Topping Q2 Estimates

NVS

MT Newswires

8 days ago

Sector Update: Health Care Stocks Fall Thursday Afternoon

NVS

Morningstar Research

8 days ago

Analyst Report: Novartis AG

NVS

MT Newswires

8 days ago

Novartis Falls Despite Earnings Beat, Guidance Raise

Novartis raises 2024 profit guidance, stock slipping though

NVS

Yahoo Finance Video

8 days ago

Novartis raises 2024 profit guidance, stock slipping though

Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs

NVS

Benzinga

8 days ago

Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs

NVS

The Wall Street Journal

8 days ago

Health Care Roundup: Market Talk

5 Things to Know Before the Stock Market Opens

NVS

Investopedia

8 days ago

5 Things to Know Before the Stock Market Opens

Novartis Reports Nearly 40% Margin In Q2; Shares Slide

NVS

Investor's Business Daily

8 days ago

Novartis Reports Nearly 40% Margin In Q2; Shares Slide

Novartis reports 43% increase in net income in Q2 2024

NVS

Pharmaceutical Technology

9 days ago

Novartis reports 43% increase in net income in Q2 2024

NVS

MT Newswires

9 days ago

Novartis Q2 Core Earnings, Revenue Advance; 2024 Outlook Updated -- Shares Drop Pre-Bell

NVS

Associated Press Finance

9 days ago

Novartis: Q2 Earnings Snapshot

Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance

NVS

GlobeNewswire

9 days ago

Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

NVS

Zacks

9 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Here’s Why Aristotle Capital’s International Equity Composite Sold Novartis AG (NVS)

NVS

Insider Monkey

11 days ago

Here’s Why Aristotle Capital’s International Equity Composite Sold Novartis AG (NVS)

Here's Why Novartis (NVS) is a Strong Value Stock

NVS

Zacks

11 days ago

Here's Why Novartis (NVS) is a Strong Value Stock

Goldman and Bank of America Earnings, ECB Rate Decision: What to Watch This Week

NVS

The Wall Street Journal

12 days ago

Goldman and Bank of America Earnings, ECB Rate Decision: What to Watch This Week

Leqembi sales inch higher; Spark’s pivot leads to layoffs

NVS

BioPharma Dive

15 days ago

Leqembi sales inch higher; Spark’s pivot leads to layoffs

UK pharma group reprimands Novo Nordisk for undisclosed payments

NVS

Pharmaceutical Technology

18 days ago

UK pharma group reprimands Novo Nordisk for undisclosed payments

Novartis Stock Generating Improved Relative Strength

NVS

Investor's Business Daily

19 days ago

Novartis Stock Generating Improved Relative Strength

NVS

MT Newswires

21 days ago

Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

NVS

Investor's Business Daily

21 days ago

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen

NVS

Zacks

a month ago

FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen

Pharma M&A: The top high value deals in 2023

NVS

Pharmaceutical Technology

a month ago

Pharma M&A: The top high value deals in 2023

Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade

NVS

Investor's Business Daily

a month ago

Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade

ASCO24: Novartis’ Scemblix outperforms standard of care in CML

NVS

Pharmaceutical Technology

a month ago

ASCO24: Novartis’ Scemblix outperforms standard of care in CML

NVS

Zacks

a month ago

Here's Why Novartis (NVS) is a Strong Value Stock

Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs

NVS

BioPharma Dive

a month ago

Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs

Here's Why Novartis (NVS) is a Strong Momentum Stock

NVS

Zacks

a month ago

Here's Why Novartis (NVS) is a Strong Momentum Stock

NVS

MT Newswires

a month ago

MorphoSys Set to Delist Following Acquisition by Novartis

Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug

NVS

Zacks

a month ago

Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug

EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial

NVS

Clinical Trials Arena

a month ago

EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial

Is Novartis AG (NYSE:NVS) Investors’ Favorite International Dividend Stock?

NVS

Insider Monkey

a month ago

Is Novartis AG (NYSE:NVS) Investors’ Favorite International Dividend Stock?

Why Novartis (NVS) is a Top Value Stock for the Long-Term

NVS

Zacks

2 months ago

Why Novartis (NVS) is a Top Value Stock for the Long-Term

Germany’s ITM raises $205M as radiopharma field booms

NVS

BioPharma Dive

2 months ago

Germany’s ITM raises $205M as radiopharma field booms

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

NVS

Zacks

2 months ago

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

Novartis (NVS) Reports Positive Long-Term Data on CSU Drug

NVS

Zacks

2 months ago

Novartis (NVS) Reports Positive Long-Term Data on CSU Drug

NVS

MT Newswires

2 months ago

Novartis Says Late-Stage Scemblix Trial Meets Primary Endpoints

NVS

MT Newswires

2 months ago

Novartis Says New Data Show Long-term Efficacy, Safety of Potential Urticaria Therapy

NVS

GlobeNewswire

2 months ago

Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML

Novartis reports Phase III data for trials of remibrutinib to treat CSU

NVS

Clinical Trials Arena

2 months ago

Novartis reports Phase III data for trials of remibrutinib to treat CSU

Novartis study points to larger role for targeted leukemia drug

NVS

BioPharma Dive

2 months ago

Novartis study points to larger role for targeted leukemia drug

Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria

NVS

GlobeNewswire

2 months ago

Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria

Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?

NVS

Zacks

2 months ago

Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?

NVS

MT Newswires

2 months ago

Goldman Sachs Starts Novartis With Buy Rating, $120 Price Target

Roche’s Sabry retires; Duchenne drug fails confirmatory test

NVS

BioPharma Dive

2 months ago

Roche’s Sabry retires; Duchenne drug fails confirmatory test

Novartis and Clarius partner for psoriatic arthritis care in Canada

NVS

Medical Device Network

2 months ago

Novartis and Clarius partner for psoriatic arthritis care in Canada

Novartis (NVS) Presents Positive Data on Renal Drugs at ERA

NVS

Zacks

2 months ago

Novartis (NVS) Presents Positive Data on Renal Drugs at ERA

Dr. Reddy’s and Novartis sign distribution agreement for anti-diabetes products

NVS

Pharmaceutical Technology

2 months ago

Dr. Reddy’s and Novartis sign distribution agreement for anti-diabetes products

Novartis’ atrasentan shows to reduce proteinuria in Phase III IgAN trial

NVS

Clinical Trials Arena

2 months ago

Novartis’ atrasentan shows to reduce proteinuria in Phase III IgAN trial

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio

NVS

GlobeNewswire

2 months ago

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo

NVS

PR Newswire

2 months ago

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo

NVS

GlobeNewswire

2 months ago

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo

Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday

NVS

Zacks

2 months ago

Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday

Latest 340B ruling delivers blow to providers

NVS

Healthcare Dive

2 months ago

Latest 340B ruling delivers blow to providers

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

NVS

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

NVS

Argus Research

2 months ago

Weekly Stock List

Erasca restructures; Novartis moves to complete MorphoSys deal

NVS

BioPharma Dive

2 months ago

Erasca restructures; Novartis moves to complete MorphoSys deal

Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash

NVS

GlobeNewswire

2 months ago

Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash

Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA

NVS

GlobeNewswire

2 months ago

Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA

3 Magnificent Stocks That Are Passive Income Machines

NVS

Motley Fool

2 months ago

3 Magnificent Stocks That Are Passive Income Machines

NVS

Thomson Reuters StreetEvents

2 months ago

Q1 2024 Legend Biotech Corp Earnings Call

Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update

NVS

GlobeNewswire

3 months ago

Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update

2 Magnificent Dividend Stocks to Hold for the Next Decade

NVS

Motley Fool

3 months ago

2 Magnificent Dividend Stocks to Hold for the Next Decade

Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y

NVS

Zacks

3 months ago

Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y

Why selling to Novartis made sense for Mariana

NVS

BioPharma Dive

3 months ago

Why selling to Novartis made sense for Mariana

NVS

MT Newswires

3 months ago

Sector Update: Health Care Stocks Softer Late Afternoon

NVS

MT Newswires

3 months ago

Sector Update: Health Care Stocks Retreat Thursday Afternoon

NVS

MT Newswires

3 months ago

Update: Novartis AG to Acquire Mariana Oncology in Deal Valued Up to $1.75 Billion.

Novartis to buy Mariana Oncology in radiopharmaceutical expansion

NVS

BioPharma Dive

3 months ago

Novartis to buy Mariana Oncology in radiopharmaceutical expansion

NVS

MT Newswires

3 months ago

Novartis AG to Acquire Mariana Oncology

NVS

Reuters

3 months ago

UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion

The top pharmaceutical companies by R&D expenditure

NVS

Pharmaceutical Technology

3 months ago

The top pharmaceutical companies by R&D expenditure

CVS stock plunges after earnings numbers one analyst 'did not even believe'

NVS

Yahoo Finance

3 months ago

CVS stock plunges after earnings numbers one analyst 'did not even believe'

Novartis Is Tracking Well Above the Industry

NVS

GuruFocus.com

3 months ago

Novartis Is Tracking Well Above the Industry

NVS

MT Newswires

3 months ago

Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications

NVS

Zacks

3 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

NVS

Argus Research

3 months ago

Analyst Report: Novartis AG

NVS

Argus Research

3 months ago

Market Digest: NVS, AN, AVB, BA, DPZ, GOOGL, KMB, SNAP

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

NVS

Zacks

3 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates

NVS

Zacks

3 months ago

Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market

NVS

Investor's Business Daily

3 months ago

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market

Novartis bags paediatric FDA label expansion for Lutathera

NVS

Pharmaceutical Technology

3 months ago

Novartis bags paediatric FDA label expansion for Lutathera

NVS

MT Newswires

3 months ago

Novartis Says New Malaria Drug Formulation Safe and Effective for Babies

Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript

NVS

Insider Monkey

3 months ago

Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript

NVS

Zacks

3 months ago

Latest Novartis AG (NVS) News on July 26, 2024

Share on Social Networks: